12 March 2010
BIOTECHNOLOGY looks at news relating to biotech companies, their financial performance, licensing, research and merger & acquisition activities. Read wide ranging reports from around the globe, backed by a massive archive from which developments in different areas can be tracked. At this time of new legislation and activities in the area of “biosimilars: or “biogenerics” approvals, which have progressed more in Europe and are likely to impact the huge US market quite soon, watching this area will be an important aspect for subscribers and those active in the sector.12 March 2010
The top one thousand UK companies invested more than £26 billion ($39.26 billion) on developing

12 March 2010
USA-based BioSante Pharmaceuticals saw its shares leap 17% to $2.00 in early trading yesterday,
11 March 2010
Transgene has signed an exclusive option agreement with Swiss drug major Novartis for the development
11 March 2010
infection, which neutralize a broad spectrum of influenza viruses, including pandemic H1N1
11 March 2010
The European Patent Office has granted German biopharmaceutical company Antisense Pharma additional
10 March 2010
US health care major Abbott Laboratories has signed a definitive agreement for Abbott to acquire
10 March 2010
On a day that saw Nasdaq trading of US biotechnology firm InterMune’s shares halted as regulators
12 March 2010 | Lifescience Lab
11 March 2010 | The Associated Press
11 March 2010 | Wealth Daily
11 March 2010 | Brookson
11 March 2010 | Press Information Bureau (press release)
11 March 2010 | Business Financial News Wire
11 March 2010 | Article Ant (press release)
10 March 2010 | ETF Trends (blog)
10 March 2010 | ETF Trends (blog)
10 March 2010 | CanadianBusiness.com
10 March 2010 | BusinessWeek